Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S292000, C546S082000
Reexamination Certificate
active
07872014
ABSTRACT:
The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
REFERENCES:
patent: 2002/0000217 (2002-01-01), Takahashi et al.
patent: 2003/0028018 (2003-02-01), Renhowe et al.
patent: 2003/0187014 (2003-10-01), Uchikawa et al.
patent: 0 574 174 (1993-12-01), None
patent: 574 174 (1993-12-01), None
patent: 06-199855 (1994-07-01), None
patent: 06199855 (1994-07-01), None
patent: 06-247966 (1994-09-01), None
patent: 06247966 (1994-09-01), None
patent: 01/02369 (2001-01-01), None
patent: 01/44244 (2001-06-01), None
patent: 01/72749 (2001-10-01), None
patent: 01/77101 (2001-10-01), None
patent: WO 01/72749 (2001-10-01), None
patent: WO 02/22598 (2002-03-01), None
patent: 02/076439 (2002-10-01), None
patent: WO 03/087095 (2003-10-01), None
Tikk et al, Journal of Chemical Research, Synopses (1987),(4), 95.
Tikk et al, Acta Chimica Hungarica (1988), 125(2),289-93.
Bogza, S. L. et al., “Convenient One Pot Synthesis of 5-Unsubstituted Pyrazolo[3,4-c]isoquinolines”, J. Heterocyclic Chem., vol. 38, 2001, 523-525.
Bogza, S. L. et al., “Intramolecular Cyclization of N-(4-Aryl-5-Pyrazolyl)-Formamidines”, Chemistry of Heterocyclic Compounds, 30(9), 1994, p. 1120.
Bogza, S. D. et al., “Cyclodesamination of N-Azolylformamidines. Synthesis of Polyazaheterocycles with Isoquinoline and Indolo[2,3-C]-Pyridine Structural Fragments”, Chemistry of Heterocyclic Compounds, 33(1), 1997, 69-73.
Almansa, C. et al., “Synthesis and SAR of a New Series of COX-2-Selective Inhibitors: Pyrazolo[1,5-a]pyrimidines”, J. Med. Chem., vol. 44, 2001, 350-361.
Pawlas, J. et al., “First Nucleophilic Aromatic Substitution of Annelated Pyrazole”, J. Org. Chem., vol. 67, 2002, 585-586.
Nikolyukin, Y. A. et al., “Recyclization of 4-Cyanobenzo[c]Pyrylium Salts Upon Reaction with Hydrazine”, Institute of Physical Organic Chemistry and Coal Chemistry, Academy of Sciences of the Ukranian SSR, Donetsk 340114, No. 7, 1987, p. 807.
Nikolyukin, Y. A. et al., “Synthesis of Azolo[5,4-c]Isoquinolines”, Institute of Physical Organic Chemisty and Coal Chemistry, Academy of Sciences of the Ukranian SSR, Donetsk, No. 8, 1991, 914-917.
Kondratov, R.V. et al., “Small Molecules that Dramatically Alter Multidrug Resistance Phenotype by Modulating the Substrate Specificity of P-glycoprotein”, PNAS, 98(24), 2001, 14078-14083.
STN International Registry Search, printed on Jan. 28, 2009, 3 pages.
Bogza, S. L. et al., “Participation of Molecular Oxygen in Cyclization of 5-Arylmethyleneamino-4-(3,4-dimethoxyphenyl)pyrazoles”, Russian Journal of Organic Chemistry, 38(4), 2002, 609-610.
Nagahira, A. et al., “Identification of a Novel Inhibitor of LPS-Induced TNF-a Production with Antiproliferative Activity in Monocyte/Macrophages”, Biochemical and Biophysical Research Communications, vol. 281, 2001, 1030-1036.
Durr, H. et al., “Cycloalkenecarbenes. X. Spiro[2,4]heptatrienes by photolysis of diazocyclopentadienes in alkynes”, Justus Liebigs Annalen Der Chemie, vol. 7, 1150-61, Aug. 16, 1974.
Ito, K. et al., “Synthesis of Furo[2,3-] isoquinoline Derivatives”, Journal of Heterocyclic Chemistry, vol. 15, 1978, pp. 301-305.
Tikk, I. et al., “Hydroxyiminoisoquinolin-3(2H)-ones. 9 [1]. Synthesis of some Oxazolo[5,4-c]-, Thiazolo[5,4-c]- and 2,3- Dihydro-1H-[1,4]oxazino[2,3-c]isoquinolines”, Journal of Heterocyclic Chemistry, vol. 25, 1988, pp. 273-277.
Rao, U. N. et al., “Convenient synthesis of 3H-pyrrolo[2,3-c]isoquinolines and 3-H-pyrrolo[2,3-c][1,7]-,3,4-benzo[c][1,7], and dihydro-pyrido [4,3-c][1,8]naphthyridines via palladium-assisted nucleophilic amination”, Heterocycles, vol. 56, 2002, pp. 443-455.
Jain, S. et al., “A novel synthesis of di(1-methylazacycloalkeno)[2,3-b:2',3'-d]py ridines through annulation on lactam acetals”, Tetrahedron Letters, 31(1), 1990, pp. 131-134.
Fischer, E. et al., “Synthesis of new sulfur heteroaromatics isoelectronic with dibenzo[g,p]chrysene by photocyclization of thienyl- and phenyl-substituted ethenes”, Journal of Organic Chemistry, vol. 61, 1996, pp. 6997-7005.
Al-Kaabi, S. S. et al., “Studies on fused 2(1H)-pyridenethiones: New routes for the synthesis of fused 1H-pyrazolo [3,4-b]pyridines and fused thieno[2,3-b]pyridines”, Bulletin of the Chemical Society of Japan, vol. 65, 1992, pp. 2241-2245.
Wiersema, A. K. et al., “Thiophene analogues of fluorene. IV. An Unusual behaviour of a cyclopentadithiophenone in the reaction with dienophiles”, Acta Chemica Scandinavica, Munksgaard, Copenhagen, DK, 24(7), 1970, pp. 2653-2665.
Tikk, I. et al., “Hydroxyiminoisouinolin-3(2H)-ones. Part 7. Rearrangemetn of 4-Hydroxyimino-1,4-dihydroisoquinolin-3 (2H) -ones under Wolfi-Semmler type reaction conditions”, Journal of Chemical Research, Miniprint, Scientific Reviews, Northwood, GB, vol. 4, No. Paper E/265/86, 1987, pp. 1101-1119.
Freslon, G. et al., “Nouveau type de cycloaddition donnant accès à un furoisobanzofuranne”, Bulletin de la Societe Chimique de France, Societe Fransaise de Chimie, Paris, France, 1974, pp. 2105-2110.
Anand Neel Kumar
Blazey Charles M.
Bowles Owen Joseph
Bussenius Joerg
Costanzo Simona
Davis Zinna N
Exelixis Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
Anaplastic lymphoma kinase modulators and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anaplastic lymphoma kinase modulators and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anaplastic lymphoma kinase modulators and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691919